Phio Pharmaceuticals Corp. (PHIO) Reports Q2 Loss of $1.47
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($1.47).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- SPAR Group (SGRP) Reports Q2 EPS of $0.04
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
